Annual Report 2025-26: Revenue up 15%, PAT flat, Dombivli opens

Ebitda Margin CompressionExceptional ItemResults View source PDF Explain this filing

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.2%Reaction day

₹1360.00

prior close

₹1363.40

announcement price

In-mkt

timing

Nifty Microcap 250market-0.1%+0.3% vs market

Hospital peers, median of 24sector+0.7%-0.4% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.3

15m

+0.1

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.2-0.1+0.3+0.7-0.4

Next day

+2.3-0.7+3.0-0.1+2.3

+2.2-1.0+3.2-0.3+2.4

+4.9+0.0+4.9+1.7+3.2

+6.3+0.2+6.1+1.3+5.0

+6.1+1.1+5.0+2.2+3.8

+7.5+0.9+6.5+1.2+6.3

15d

+14.0+0.8+13.3+2.3+11.7

—-0.8—+0.7—

—+5.0—-1.2—

—+5.0—-0.4—

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jupiter Life Line Hospitals posted FY26 revenue of Rs 1,499.78 Cr, up 15% YoY, with EBITDA at Rs 343.30 Cr (22.89% margin, down from 23.50%). PAT was largely flat at Rs 194.20 Cr vs Rs 193.80 Cr. The new Dombivli hospital (200 beds, 500 total planned) opened in February 2026. Occupancy dipped to 61.2% from 65.3%, though ARPOB rose to Rs 67,700. AGM on July 17, 2026.

Likely market impact

Strong revenue growth from new hospital ramp-up, but flat PAT and margin compression signal cost pressures. Watch occupancy recovery.